The airborne transmission
of the COVID-19 virus has been suggested
as a major mode of transmission in recent studies. In this context,
we studied the spatial transmission of COVID-19 vectors in an indoor
setting representative of a typical office room. Computational fluid
dynamics (CFD) simulations were performed to study the airborne dispersion
of particles ejected due to different respiratory mechanisms, i.e.,
coughing, sneezing, normal talking, and loud talking. Number concentration
profiles at a distance of 2 m in front of the emitter at the ventilation
rates of 4, 6, and 8 air changes per hour (ACH) were estimated for
different combinations of inlet–outlet positions and emitter–receptor
configurations. Apart from respiratory events, viz., coughing and
sneezing characterized by higher velocity and concentration of ejected
particles, normal as well as loud talking was seen to be carrying
particles to the receptor for some airflow patterns in the room. This
study indicates that the ″rule of thumb based safe distance
approach″ cannot be a general mitigation strategy for infection
control. Under some scenarios, events with a lower release rate of
droplets such as talking (i.e., asymptomatic transmission) can lead
to a high concentration of particles persisting for long times. For
better removal, the study suggests ″air curtains″ as
an appropriate approach, simultaneously highlighting the pitfalls
in the ″higher ventilation rate for better removal″
strategy. The inferences for talking-induced particle transmissions
are crucial considering that large populations of COVID-19-infected
persons are projected to be asymptomatic transmitters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.